Thierry Bernard

CEO, QIAGEN, Boston/ USA & Hilden/Germany

Leading in times of crisis.

Thierry Bernard, CEO of Qiagen (c) QIAGEN
Thierry Bernard, CEO of Qiagen (c) QIAGEN


Thierry Bernard joined QIAGEN in February 2015 to lead the company’s growing presence in molecular diagnostics, the application of Sample to Insight solutions for molecular testing in human healthcare. He was named Chief Executive Officer in March 2020 after serving in this role on an interim basis and became a member of the Managing Board in 2021.
Previously, Mr. Bernard held roles of increasing responsibility during 15 years with bioMérieux SA, most recently as Corporate Vice President, Global Commercial Operations, Investor Relations and the Greater China Region, and held senior management roles in several other leading international companies.
He has been a member of the Board of Directors of T2 Biosystems, Inc., a publicly listed company based in the U.S., since 2020. He was named in March 2023 as Chair of the AdvaMedDx Board of Directors, a U.S. industry trade association.
Mr. Bernard has earned degrees and certifications from Sciences Po, LSE, the College of Europe, Harvard Business School, Centro de Comercio Exterior de Barcelona, and has been appointed Conseiller du Commerce Extérieur by the French government. 

  • Tuesday, November 28, 2023
  • 12:30
  • Online


Mag. Bettina Stichauner | Head Alumni Center Alumni Center & Events
Mag. Bettina Stichauner Head Alumni Center +43 512 2070 - 1700